Whitehouse Jacqueline P, Howlett Meegan, Federico Aniello, Kool Marcel, Endersby Raelene, Gottardo Nicholas G
Brain Tumour Research Program, Telethon Kids Institute, Nedlands, Western Australia, Australia.
Centre for Child Health Research, University of Western Australia, Nedlands, Western Australia, Australia.
Neurooncol Adv. 2021 Aug 12;3(1):vdab109. doi: 10.1093/noajnl/vdab109. eCollection 2021 Jan-Dec.
Cranial radiation therapy is essential in treating many pediatric cancers, especially brain tumors; however, its use comes with the risk of developing second malignancies. Cranial radiation-induced gliomas (RIGs) are aggressive high-grade tumors with a dismal prognosis, for which no standard therapy exists. A definitive molecular signature for RIGs has not yet been established. We sought to address this gap by performing a systematic review and meta-analysis of the molecular features of cranial RIGs.
A systematic review of the literature was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Articles and case reports that described molecular analyses of cranial radiation-induced high-grade gliomas were identified and evaluated, and data extracted for collation.
Of 1727 records identified, 31 were eligible, containing 102 unique RIGs with molecular data. The most frequent genetic alterations in RIGs included or mutations, or amplifications, and deletion, along with 1q gain, 1p loss and 13q loss. Of note, mutations in , , , , , , or the promoter were not observed. A comparative analysis revealed that RIGs are molecularly distinct from most other astrocytomas and gliomas and instead align most closely with the pedGBM_RTK1 subgroup of pediatric glioblastoma.
This comprehensive analysis highlights the major molecular features of RIGs, demonstrates their molecular distinction from many other astrocytomas and gliomas, and reveals potential genetic drivers and therapeutic targets for this currently fatal disease.
颅脑放射治疗在许多儿童癌症尤其是脑肿瘤的治疗中至关重要;然而,其应用伴随着发生第二原发性恶性肿瘤的风险。颅脑放射诱发的胶质瘤(RIGs)是侵袭性高级别肿瘤,预后不佳,目前尚无标准治疗方法。RIGs的明确分子特征尚未确立。我们试图通过对颅脑RIGs的分子特征进行系统评价和荟萃分析来填补这一空白。
根据系统评价和荟萃分析的首选报告项目指南对文献进行系统评价。识别并评估描述颅脑放射诱发的高级别胶质瘤分子分析的文章和病例报告,并提取数据进行整理。
在识别出的1727条记录中,31条符合要求,包含102个具有分子数据的独特RIGs。RIGs中最常见的基因改变包括 或 突变、 或 扩增、 缺失,以及1q增益、1p缺失和13q缺失。值得注意的是,未观察到 、 、 、 、 、 、 或 启动子的突变。比较分析显示,RIGs在分子水平上与大多数其他星形细胞瘤和胶质瘤不同,而是与儿童胶质母细胞瘤的pedGBM_RTK1亚组最为相似。
这项综合分析突出了RIGs的主要分子特征,证明了它们与许多其他星形细胞瘤和胶质瘤在分子水平上的差异,并揭示了这种目前致命疾病的潜在基因驱动因素和治疗靶点。